Paper28972796
PET imaging in anal canal cancer: a systematic review and meta-analysis.
Mahmud A and 2 others. Br J Radiol, 2017. Cited by 62 papers, by iCite.
Cite this record
ConductScience Library. PET imaging in anal canal cancer: a systematic review and meta-analysis. Papers, record 28972796. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28972796
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anus Neoplasms | Major topic |
| Positron-Emission Tomography | Major topic |
| Anal Canal | |
| Humans |
Source PubMed
References40
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23208584 | MRI and CT of anal carcinoma: a pictorial review. | Insights Imaging | 2013 | https://conductscience.org/library/papers/23208584 | PubMed |
| 2 | 8823332 | Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. | J Clin Oncol | 1996 | https://conductscience.org/library/papers/8823332 | PubMed |
| 3 | 22294527 | To PET or not to PET? That is the question. Staging in anal cancer. | Ann Oncol | 2012 | https://conductscience.org/library/papers/22294527 | PubMed |
| 4 | 19259091 | The impact of 18-fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancer. | Br J Cancer | 2009 | https://conductscience.org/library/papers/19259091 | PubMed |
| 5 | 19370429 | Can the radiation dose to CT-enlarged but FDG-PET-negative inguinal lymph nodes in anal cancer be reduced? | Strahlenther Onkol | 2009 | https://conductscience.org/library/papers/19370429 | PubMed |
| 6 | 26126968 | Anal cancer FDG-PET standard uptake value: correlation with tumor characteristics, treatment response and survival. | Radiol Med | 2016 | https://conductscience.org/library/papers/26126968 | PubMed |
| 7 | 18614927 | Incidence and epidemiology of anal cancer in the multicenter AIDS cohort study. | J Acquir Immune Defic Syndr | 2008 | https://conductscience.org/library/papers/18614927 | PubMed |
| 8 | 19404066 | Outcomes and prognostic factors for squamous-cell carcinoma of the anal canal: analysis of patients from the National Cancer Data Base. | Dis Colon Rectum | 2009 | https://conductscience.org/library/papers/19404066 | PubMed |
| 9 | 16028002 | Positron Emission Tomography for pretreatment staging and posttreatment evaluation in cancer of the anal canal. | Mol Imaging Biol | 2005 | https://conductscience.org/library/papers/16028002 | PubMed |
| 10 | 22915424 | Imaging of anal carcinoma. | AJR Am J Roentgenol | 2012 | https://conductscience.org/library/papers/22915424 | PubMed |
| 11 | 9164216 | Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. | J Clin Oncol | 1997 | https://conductscience.org/library/papers/9164216 | PubMed |
| 12 | 21061012 | Impact of FDG PET/CT in the staging and the follow-up of anal carcinoma. | Int J Colorectal Dis | 2011 | https://conductscience.org/library/papers/21061012 | PubMed |
| 13 | 19736891 | Squamous cell carcinoma of the anal canal. | Surgeon | 2009 | https://conductscience.org/library/papers/19736891 | PubMed |
| 14 | 25239441 | Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. | Eur J Surg Oncol | 2014 | https://conductscience.org/library/papers/25239441 | PubMed |
| 15 | 19926961 | Anal cancers among HIV-infected persons: HAART is not slowing rising incidence. | AIDS | 2010 | https://conductscience.org/library/papers/19926961 | PubMed |
| 16 | 19394179 | FDG-PET/CT: new horizons in anal cancer. | Gastroenterol Clin Biol | 2009 | https://conductscience.org/library/papers/19394179 | PubMed |
| 17 | 15494916 | Trends in AIDS-defining and non-AIDS-defining malignancies among HIV-infected patients: 1989-2002. | Clin Infect Dis | 2004 | https://conductscience.org/library/papers/15494916 | PubMed |
| 18 | 16626889 | FDG-PET/CT in the evaluation of anal carcinoma. | Int J Radiat Oncol Biol Phys | 2006 | https://conductscience.org/library/papers/16626889 | PubMed |
| 19 | 20231040 | Anal cancer maximum F-18 fluorodeoxyglucose uptake on positron emission tomography is correlated with prognosis. | Radiother Oncol | 2010 | https://conductscience.org/library/papers/20231040 | PubMed |
| 20 | 21685461 | Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. | CA Cancer J Clin | 2011 | https://conductscience.org/library/papers/21685461 | PubMed |
Cited by37
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 62 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42582979 | Optimising chemoradiotherapy in anal cancer. | ESMO Gastrointest Oncol | 2026 | https://conductscience.org/library/papers/42582979 | PubMed |
| 42255977 | Predicting locoregional treatment failure in anal cancer using multivariable clinical-imaging models. | Clin Transl Radiat Oncol | 2026 | https://conductscience.org/library/papers/42255977 | PubMed |
| 42073557 | Imaging Biomarkers in Radiotherapy. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42073557 | PubMed |
| 41555561 | Diagnostic and Therapeutic Impact of FDG-PET/CT Following MRI Staging in Anal Cancer: A Systematic Review and Meta-Analysis. | J Med Imaging Radiat Oncol | 2026 | https://conductscience.org/library/papers/41555561 | PubMed |
| 40963852 | Clinical evaluation of atlas-based auto-segmentation for contouring pelvic CTVs in the treatment of anal cancer with FDG-PET-positive lymph node involvement. | Front Oncol | 2025 | https://conductscience.org/library/papers/40963852 | PubMed |
| 39542884 | Interstitial HDR brachytherapy for anal cancer-results and quality of life. | Strahlenther Onkol | 2025 | https://conductscience.org/library/papers/39542884 | PubMed |
| 39390445 | Investigation of the distribution of inguinal lymph nodes and delineation of the inguinal clinical target volume using 18F-FDG PET/CT. | BMC Cancer | 2024 | https://conductscience.org/library/papers/39390445 | PubMed |
| 39312693 | Anal carcinoma - exploring the epidemiology, risk factors, pathophysiology, diagnosis, and treatment. | World J Exp Med | 2024 | https://conductscience.org/library/papers/39312693 | PubMed |
| 37736988 | An Updated Review on Imaging and Staging of Anal Cancer-Not Just Rectal Cancer. | Tomography | 2023 | https://conductscience.org/library/papers/37736988 | PubMed |
| 37592085 | [18F]-FDG PET in anal canal cancer: a systematic review and meta-analysis. | Eur J Nucl Med Mol Imaging | 2023 | https://conductscience.org/library/papers/37592085 | PubMed |
| 37296929 | The Role of MRI and PET/CT in Radiotherapy Target Volume Determination in Gastrointestinal Cancers-Review of the Literature. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37296929 | PubMed |
| 37042989 | [Diagnostics, treatment and aftercare of anal cancer]. | Chirurgie (Heidelb) | 2023 | https://conductscience.org/library/papers/37042989 | PubMed |
| 37024606 | Follow-up imaging of anal cancer after treatment. | Abdom Radiol (NY) | 2023 | https://conductscience.org/library/papers/37024606 | PubMed |
| 36975459 | Anal Cancer: The Past, Present and Future. | Curr Oncol | 2023 | https://conductscience.org/library/papers/36975459 | PubMed |
| 36932225 | Imaging of Anal Squamous Cell Carcinoma: Survey Results and Expert Opinion from the Rectal and Anal Cancer Disease-Focused Panel of the Society of Abdominal Radiology. | Abdom Radiol (NY) | 2023 | https://conductscience.org/library/papers/36932225 | PubMed |
| 36862155 | Impact of dose escalation on colostomy-free survival and treatment outcome in squamous cell anal carcinoma. | Strahlenther Onkol | 2023 | https://conductscience.org/library/papers/36862155 | PubMed |
| 36611345 | The Role of Positron Emission Tomography and Computed Tomographic (PET/CT) Imaging for Radiation Therapy Planning: A Literature Review. | Diagnostics (Basel) | 2022 | https://conductscience.org/library/papers/36611345 | PubMed |
| 35908126 | Utility of PET Scans in the Diagnosis and Management of Gastrointestinal Tumors. | Dig Dis Sci | 2022 | https://conductscience.org/library/papers/35908126 | PubMed |
| 35719920 | Intensity-Modulated Radiotherapy Associated With Improved Survival Outcome in Anal Cancer. | Front Oncol | 2022 | https://conductscience.org/library/papers/35719920 | PubMed |
| 35406469 | A Machine-Learning-Based Bibliometric Analysis of the Scientific Literature on Anal Cancer. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35406469 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28972796
GET https://conductscience.org/api/papers/v1/28972796/references?page=2